Stage III Thymoma AJCC v8
1 clinical trials · Condition
◉ Watch Stage III Thymoma AJCC v8
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer (NCT03295227) | M.D. Anderson Cancer Center | 2017-12-06 |
Track Stage III Thymoma AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.